University Hospitals Plymouth NHS Trust

FSD Pharma Inc Incorporates New Subsidiary to Capitalize on Drug Development Incentives in Australia

Retrieved on: 
Monday, January 9, 2023

“We are excited about the incorporation of FSD Pharma Australia, where we have an excellent opportunity to advance our pipeline,” said Mr. Zeeshan Saeed, President of FSD Pharma.

Key Points: 
  • “We are excited about the incorporation of FSD Pharma Australia, where we have an excellent opportunity to advance our pipeline,” said Mr. Zeeshan Saeed, President of FSD Pharma.
  • “Australia is a hotbed for clinical stage biotech companies, and our drug development programs will be able to take advantage of facilities offered by various government incentives in Australia,” added Mr. Saeed.
  • Chataway, Dhanda and Lê have agreed to join our international panel to contribute to our current and new programs,” said Dr. Lakshmi Kotra, CEO of Lucid Psycheceuticals, a wholly owned subsidiary of FSD Pharma.
  • Dr. Chataway received his Bachelor of Medicine & Surgery from Oxford University, and Doctor of Philosophy from Cambridge University.

FS50731513

Retrieved on: 
Wednesday, December 12, 2018

The complainant has requested information relating to a number of University Hospitals Plymouth NHS Trust (previously known as Plymouth Hospitals NHS Trust) (the Trust) reports from 2017. The Commissioner’s decision is that the Trust is entitled to rely section 14(1) of the FOIA in response to the request. However, the Commissioner also finds that the Trust breached section 10 (time for compliance) of the FOIA by not providing the information requested at part 2, within 20 working days. As the information has now been provided the Commissioner does not require the public authority to take any steps.

Key Points: 
  • The complainant has requested information relating to a number of University Hospitals Plymouth NHS Trust (previously known as Plymouth Hospitals NHS Trust) (the Trust) reports from 2017.
  • The Commissioners decision is that the Trust is entitled to rely section 14(1) of the FOIA in response to the request.
  • However, the Commissioner also finds that the Trust breached section 10 (time for compliance) of the FOIA by not providing the information requested at part 2, within 20 working days.
  • As the information has now been provided the Commissioner does not require the public authority to take any steps.